Interleukin‐22 and interleukin‐22–producing NKp44+ natural killer cells in subclinical gut inflammation in ankylosing spondylitis
Francesco Ciccia(University of Campania "Luigi Vanvitelli"), G Triolo(Department of Health)
Cited by 128
Related Papers
Early Disease and Low Baseline Damage as Predictors of Response to Belimumab in Patients With Systemic Lupus Erythematosus in a Real‐Life Setting
|Arthritis & Rheumatology|2020|113